Categories Articles A big drugmaker is backing away from a plan to triple the price of a lifesaving cancer drug after facing a public backlash Post author By crystalg Post date May 15, 2018 Business Insider Feedburner Tags After, away, backing, Backlash, Cancer, drug, drugmaker, Facing, from, LifeSaving, Plan, Price, public, Triple ← For a More Productive Workplace, Welcome Breastfeeding Moms Back to Their Jobs → John Travolta Dances on Stage with 50 Cent at Cannes